News

Community Engagement through Drama

Dr. Gill Black

Listen to Gill Black Podcast

Summary: Dr. Gill Black is the co-founder and Director of Health and Welfare at The Sustainable Livelihoods Foundation (SLF). In this inteview, we discuss with Dr. Black one of SLF’s groundbreaking projects that uses drama to engage local communities around issues related to TB and HIV/AIDS. The goal of the foundation is to contribute towards eliminating poverty through undertaking original research and engaging with communities to develop and advance innovative approaches to strengthening livelihoods. SLF undertakes several projects to achieve its objectives:

  • To undertake path-breaking, state of the art, pragmatic research into the constraints and obstacles to human development and make this knowledge accessible to a wider audience, through simplification and audio and visual communication
  • To undertake creative public engagement with communities, learning of their challenges and equipping them with knowledge and skills to foster resilience and strengthen their livelihood opportunities
  • To conceptualize and pioneer innovative development practice to influence policy and programs and to apply these ideas through micro-projects to demonstrate their effectiveness and sustainability

Sustainable Livelihood Foundation Gallery

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...